30.08.2011

First UK Patient Enrolled into Luminous™ Programme – Novartis’ 30,000 Patient Observational Study in Ophthalmolog

Novartis has enrolled the first UK patient into the Luminous™ programme. The programme aims to advance understanding of retinal vascular diseases. Pharmaceutical Business Review, a website covering all aspects of pharmaceutical news, such as clinical trials and drugs research, covered the story. This site is a great site for Novartis to achieve coverage on as it will reach industry professionals interested in the latest pharmaceutical research news.

Coverage

Pharmaceutical Business Review

RealWire Influence Rating

Novartis Pharma recruits first patient in Lucentis study

Pharmaceutical Business Review is a site providing latest pharmaceutical news, comment and industry information it also offers content that is produced by a dedicated team of journalists and global industry experts. In addition to the free content made available on the sites an intelligence store will provides users with market analysis reports from global suppliers of market research and industry analysis.

---